Skip to content

Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)

Clinical Outcomes of Olfactory Training for Treatment of Olfactory Dysfunction After COVID-19

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04764981
Enrollment
350
Registered
2021-02-21
Start date
2021-05-31
Completion date
2024-05-01
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anosmia, Covid19, Olfactory Disorder, SARS-CoV Infection

Brief summary

It is a randomized controlled clinical trial study that aims to follow a sample of individuals with persistent olfactory dysfunction post-COVID-19. The aim of this study is assess the clinical outcomes of olfactory training therapy in the treatment of persistent olfactory dysfunctions after COVID-19. The sample will consist of 350 participants, being 300 individuals with persistent olfactory dysfunction post-COVID-19 and 50 healthy individuals. Volunteers' will be separated in two experimental groups (1 and 2 ) and a control group. All participants will be submitted to clinical evaluation that include the Connecticut Chemosensory Clinical Research Test (CCCRT), an olfactory test to diagnose anosmia and hyposmia, and two skull Magnetic Resonance imaging (MRI). Only participants of Experimental group 1 will be submitted to an olfactory training with essences oils. Experimental group 2 will only receive a clinical follow-up after three months and control group will be only submitted to neurological exam, olfactory test, MRI imaging and test their ability to discriminate the essence oils used in olfactory training. As a result, is expected a better understanding of the characteristics of olfactory dysfunction caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus infection, as well as the effectiveness and viability of using Olfactory Training as a therapeutic alternative.

Interventions

OTHEREssence oils

Consists in olfactory training using essence oils

Sponsors

Universidade do Estado do Pará
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants of groups will be evaluated and random inserted in one of the experimental groups. The person responsible for reassessment will be blinded for which group the individual reassessed came from.

Intervention model description

Randomized controlled clinical trial study, with 2 experimental groups

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Confirmed diagnosis of COVID-19 by Real Time Polymerase chain-reaction for SARS-CoV-2 or serological tests for SARS-CoV-2 antigens.\\ * Olfactory dysfunction confirmed by Connecticut Chemosensory Clinical Research Test (CCCRC-T).

Exclusion criteria

* Smokers * Individuals with diagnosed rhinitis * Individuals with diagnosed Neurological diseases * Individuals submitted to brain surgery * Previous historic of hyposmia and/ or anosmia * Pregnancy * Allergy to any of the substances present in the olfactory test kit * Individuals who are undergoing another treatment for olfactory dysfunction

Design outcomes

Primary

MeasureTime frameDescription
To Assess the effectiveness of olfactory training therapy in the treatment of persistent olfactory dysfunctions after COVID-194 yearsThe individuals of Experimental group 1 will be submitted to a olfactory training with essence oils, the participants will be reassessed with Olfactory test CCCRT monthly and this results will be compared with the reassessment results of the Experimental group 2 (no intervention group). The results of CCCRT of these two groups will be compared with Control group. The CCCRT olfactory test consists of n-butanol smell threshold test and smell identification test. Olfactory function score will be assessed (0: worst score; 7: best score).

Secondary

MeasureTime frameDescription
To Investigate by means of skull nuclear magnetic resonance (MRI) exams for possible neural correlates of olfactory dysfunctions present in post-COVID-19 patients4 yearsMRI imaging of olfactory bulb will be assessed in the individuals of this study, for better understanding of possible lesions at neural sites
To Measure by means of a standardized olfactory test the olfactory dysfunctions present in post-COVID-19 patients4 yearsCCCRT will be used to classify individuals as having normosmia, hyposmia or anosmia
Propose an olfactory training protocol appropriate to the demands of patients with post-COVID-19 olfactory dysfunction and in accordance with the reality of Brazilian public health services4 yearsThe olfactory training using essence oils will be tested in this study as a low cost alternative for therapeutics

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026